Cheikh Loucoubar - Epidemiology

Author Information

Cheikh Loucoubar is a distinguished researcher affiliated with the Epidemiology, Clinical Research and Data Science Department at the Institut Pasteur de Dakar, located at 36, Avenue Pasteur, BP 220, Dakar, Senegal. His work primarily focuses on epidemiology and data science, with a particular emphasis on infectious diseases and public health interventions.

Research Contributions

Cheikh Loucoubar has made significant contributions to the field of epidemiology, particularly in the context of infectious diseases in Senegal. His recent research includes studies on COVID-19 vaccination strategies, seroprevalence of anti-SARS-CoV-2 antibodies, epidemiological and virological insights into COVID-19 among children, and the detection of Rift Valley Fever Virus. He has also conducted extensive research on Dengue virus and HPV genotypes in women with cervical cancer. His work has provided valuable insights into the co-circulation of different dengue virus serotypes and the genetic diversification of these viruses in Senegal.

Aliases

Cheikh Loucoubar is also known by the aliases C Loucoubar and C. Loucoubar.

Publication and Citation Metrics

Metric	Value
Citation Count	1189
H-Index	16
Paper Count	89

Publications:

Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study

DOI: 10.1136/bmjgh-2021-007236

Year: 2022

Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020

DOI: 10.1016/j.ijregi.2022.02.007

Year: 2022

COVID-19 and Children in Senegal: Epidemiological and Virological Insights

DOI: 10.26502/acbr.50170250

Year: 2022

Detection of Rift Valley Fever Virus Lineage H From South Africa Through the Syndromic Sentinel Surveillance Network in Senegal

DOI: 10.1093/ofid/ofab655

Year: 2022

Full Genome Analysis of Circulating DENV-2 in Senegal Reveals a Regional Diversification Into Separate Clades

DOI: 10.20944/preprints202201.0057.v1

Year: 2022

Field Deployment of a Mobile Biosafety Laboratory Reveals the Co-Circulation of Dengue Viruses Serotype 1 and Serotype 2 in Louga City, Senegal, 2017

DOI: 10.1155/2021/8817987

Year: 2021

Hydroxychloroquine and Azithromycin Treatment of Hospitalized Patients Infected with SARS-CoV-2 in Senegal from March to October 2020

DOI: 10.3390/jcm10132954

Year: 2021

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.

DOI: 10.1038/s41586-021-03901-9

Year: 2021

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Senegal: A National Population-Based Cross-Sectional Survey, between October and November 2020

DOI: 10.2139/ssrn.3925475

Year: 2021

HPV genotypes and epidemiology in women cervical cancer in Senegal.

DOI: 10.21203/rs.2.15323/v4

Year: 2021

What Methods are Used in Epidemiological Studies of Pesticides?

What is The Lancet?

What is Acidic pH?

How Can Epidemiology Help in Addressing Stress and Mental Health?

How are Resistant Infections Monitored?

What are the Key Indicators of Malnutrition?

What Types of Donations are Essential?

How Prevalent is VVC?

How Does Environmental Control Help?

How do advancements in technology contribute to reducing animal use?

Partnered Content Networks

Relevant Topics